The Government is eager to provide healthcare to all Indonesians by 2019 through its universal healthcare program. Demand for medicines is estimated to rise drastically (especially for the cheaper generic medicines) as tens of millions of additional Indonesians will have greater access to government-subsidized healthcare. As such, the development of a domestic industry that can produce raw materials needed in the pharmaceutical sector is now an urgent necessity.To subscribe please click here